Application 089298
- Type
- ANDA
- Sponsor
- QUAD PHARMS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | NANDROLONE PHENPROPIONATE | NANDROLONE PHENPROPIONATE | Injectable; Injection | 50MG/ML | No | No |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.